DMU2105

CAS No. 1031063-36-1

DMU2105( —— )

Catalog No. M22627 CAS No. 1031063-36-1

DMU2105 is a specific CYP1B1 inhibitor(CYP1B1 and CYP1A1 with IC50 of 10 nM and 742 nM, respectively)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 93 In Stock
2MG 59 In Stock
5MG 86 In Stock
10MG 126 In Stock
25MG 227 In Stock
50MG 335 In Stock
100MG 502 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DMU2105
  • Note
    Research use only, not for human use.
  • Brief Description
    DMU2105 is a specific CYP1B1 inhibitor(CYP1B1 and CYP1A1 with IC50 of 10 nM and 742 nM, respectively)
  • Description
    DMU2105 is a specific CYP1B1 inhibitor(CYP1B1 and CYP1A1 with IC50 of 10 nM and 742 nM, respectively).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    CYP1B1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1031063-36-1
  • Formula Weight
    259.3
  • Molecular Formula
    C18H13NO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(\C=C\c1ccc2ccccc2c1)c1cccnc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Horley N J , Beresford K J M , Chawla T , et al. Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines[J]. European Journal of Medicinal Chemistry, 2017, 129:159-174.
molnova catalog
related products
  • ε-?Viniferin

    ε-Viniferin a dimer of resveratrol, shows the inhibitory effects of epsilon-viniferin on human CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2B6, CYP2E1, CYP3A4 and CYP4A activities.

  • Ginsenoside Rg2

    Ginsenoside Rg2 is one of the major active components of ginseng, act as an NF-κB inhibitor.

  • JNJ0966

    JNJ0966 is a highly selective MMP-9 zymogen inhibitor (IC50: 440 nM).